Skip to content

The efficacy of panchromoendoscopy during gastric endoscopic submucosal dissection

The efficacy of panchromoendoscopy for the detection of synchronous lesion before endoscopic submucosal dissection for gastric tumor: A prospective, multicenter, randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003835
Enrollment
314
Registered
2019-04-23
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : 1) Patients who visited the gastroenterologist outpatient clinic and were diagnosed as gastric tumor, entered the selection criteria, and underwent endoscopic gastric submucosal di
1&quot
, and C-HDE group is assigned &quot
2&quot
. 3) If you are assigned to the PCE group, proceed through the following procedure. Before endoscopic submucosal dissection, endoscopy is used to identify the target lesions. And indigo carmine is app
and 30 mL of Indigo carmine is applied using a spray catheter. The endoscope used in the PCE group is the same endoscope as the endoscope of C-HDE and additionally carries indigo carmine. After applic

Sponsors

Yonsei University, Wonju Severance Christian Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 19 - 80 years old (2) Patients who were diagnosed with gastric adenoma or early gastric cancer and who underwent endoscopic submucosal dissection (3) Patients without metastasis to other sites other than stomach (4) Patients who did not had an endoscope directly the endoscopist (will be endoscopic submucosal dissection) (5) Patients who agreed with the explanation of the study

Exclusion criteria

Exclusion criteria: (1) Severe systemic or coagulopathic disorders (2) Had previous endoscopic treatment with gastric tumor (3) Patients who are pregnant or lactating (4) When taking antiplatelet or anticoagulant (5) Patients with a history of gastrectomy

Design outcomes

Primary

MeasureTime frame
The detection rate of synchronous lesions

Secondary

MeasureTime frame
The difference in endoscopic biopsy count;The difference of taken time before endoscopic submucosal dissection;Characteristics of detected synchronous lesions

Countries

Korea, Republic of

Contacts

Public ContactSu Young Kim

Yonsei University, Wonju Severance Christian Hospital

breeze1212@naver.com+82-33-741-1229

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026